Szeged, Hungary

István Mándity

This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Szegedi Tudomanyegyetem. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: István Mándity. Retrieved from https://idiyas.com/inventor/istván-mándity

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of István Mándity

Introduction

István Mándity is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new morphine derivatives. His work focuses on enhancing the efficacy and safety of pain management treatments.

Latest Patents

Mándity holds a patent for "Deuterated morphine derivatives." This invention relates to new morphine derivatives that are deuterated at the 7,8-position of the morphine ring. The patent outlines a process for the preparation of these derivatives and pharmaceutical compositions that include them. The new deuterated morphine derivatives exhibit high and selective μ-opioid receptor binding activity. This leads to higher analgesic activity at lower dosages, thereby reducing adverse effects compared to traditional hydrogenated derivatives. These compounds are particularly useful in treating pain and can also serve as antitussive agents with a lower risk of drug abuse.

Career Highlights

Mándity is affiliated with Szegedi Tudományegyetem, where he conducts his research and development work. His innovative approach to pharmaceutical chemistry has positioned him as a key figure in the field.

Collaborations

Mándity has collaborated with notable colleagues, including Ferenc Fülöp and Balázs Olasz. Their combined expertise contributes to the advancement of research in pharmaceutical applications.

Conclusion

István Mándity's contributions to the development of deuterated morphine derivatives represent a significant advancement in pain management therapies. His work not only enhances the effectiveness of treatment but also aims to minimize the risks associated with traditional opioid medications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…